Industry Research Reports
Home > Reports > Medical Devices & Consumables > Neurovascular Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Neurovascular Devices- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Medical Devices & Consumables
Published Date: 2025-01-16
Pages: 109 Pages
Report ld: 3476118
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Neurovascular Devices Market Size(US$)
CAGR 2025-2031
5.5%
Market Size,2031
USD 297
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 216 million
Market Forecast in 2031(Value)
US$ 297 million
CAGR
5.5%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Neurovascular Devices was estimated to be worth US$ 205 million in 2024 and is forecast to a readjusted size of US$ 297 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.
Neurovascular Devices refer to the tools that used to pass through the blood vessels to diagnose and treat diseases and conditions of the brain and nervous system rather than using open surgery. Neurovascular Devices comprise a large segment of medical devices, including embolic coils, neurovascular stents (carotid and intracranial stents), intravascular devices, neurothrombectomy devices, flow diverters, embolic protection device, balloons and stent retrievers.
Top players in the neurovascular devices market are Stryker Corporation and Medtronic, Johnson & Johnson, Terumo Corporation, Penumbra, Abbott Laboratories, W. L. Gore & Associates, Microport Scientific Corporation and some others are also key players in this field.
Geographically, the neurovascular devices market is classified into North America, Europe, Japan, China and The Rest. North America dominates the global market, followed by Europe and Japan.
On the basis of product, the neurovascular devices market is classified into four major segments—aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems, support devices, and neurothrombectomy devices. The aneurysm coiling and embolization devices segment is the largest and accounts for about 37% of the global neurovascular devices market.
Neurovascular devices are widely used in hospitals, clinics and ambulatory surgical units.
This report aims to provide a comprehensive presentation of the global market for Neurovascular Devices, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Neurovascular Devices by region & country, by Type, and by Application.
The Neurovascular Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurovascular Devices.
MARKET SEGMENTATION
By Company
- Stryker Corporation
- Johnson & Johnson
- Medtronic
- Terumo
- Penumbra
- Microport Scientific Corporation
- Abbott Vascular
- W. L. Gore & Associates
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Aneurysm Coiling & Embolization Devices
- Cerebral Balloon Angioplasty & Stenting Systems
- Support Devices
- Neurothrombectomy Devices
Segment by Application
- Hospitals
- Clinics
- Ambulatory Surgical Units
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Neurovascular Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Neurovascular Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Neurovascular Devices in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Neurovascular Devices Product Introduction
1.2 Global Neurovascular Devices Market Size Forecast
1.2.1 Global Neurovascular Devices Sales Value (2020-2031)
1.2.2 Global Neurovascular Devices Sales Volume (2020-2031)
1.2.3 Global Neurovascular Devices Sales Price (2020-2031)
1.3 Neurovascular Devices Market Trends & Drivers
1.3.1 Neurovascular Devices Industry Trends
1.3.2 Neurovascular Devices Market Drivers & Opportunity
1.3.3 Neurovascular Devices Market Challenges
1.3.4 Neurovascular Devices Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Neurovascular Devices Players Revenue Ranking (2024)
2.2 Global Neurovascular Devices Revenue by Company (2020-2025)
2.3 Global Neurovascular Devices Players Sales Volume Ranking (2024)
2.4 Global Neurovascular Devices Sales Volume by Company Players (2020-2025)
2.5 Global Neurovascular Devices Average Price by Company (2020-2025)
2.6 Key Manufacturers Neurovascular Devices Manufacturing Base and Headquarters
2.7 Key Manufacturers Neurovascular Devices Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Neurovascular Devices
2.9 Neurovascular Devices Market Competitive Analysis
2.9.1 Neurovascular Devices Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Neurovascular Devices Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurovascular Devices as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Aneurysm Coiling & Embolization Devices
3.1.2 Cerebral Balloon Angioplasty & Stenting Systems
3.1.3 Support Devices
3.1.4 Neurothrombectomy Devices
3.2 Global Neurovascular Devices Sales Value by Type
3.2.1 Global Neurovascular Devices Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Neurovascular Devices Sales Value, by Type (2020-2031)
3.2.3 Global Neurovascular Devices Sales Value, by Type (%) (2020-2031)
3.3 Global Neurovascular Devices Sales Volume by Type
3.3.1 Global Neurovascular Devices Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Neurovascular Devices Sales Volume, by Type (2020-2031)
3.3.3 Global Neurovascular Devices Sales Volume, by Type (%) (2020-2031)
3.4 Global Neurovascular Devices Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Ambulatory Surgical Units
4.2 Global Neurovascular Devices Sales Value by Application
4.2.1 Global Neurovascular Devices Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Neurovascular Devices Sales Value, by Application (2020-2031)
4.2.3 Global Neurovascular Devices Sales Value, by Application (%) (2020-2031)
4.3 Global Neurovascular Devices Sales Volume by Application
4.3.1 Global Neurovascular Devices Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Neurovascular Devices Sales Volume, by Application (2020-2031)
4.3.3 Global Neurovascular Devices Sales Volume, by Application (%) (2020-2031)
4.4 Global Neurovascular Devices Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Neurovascular Devices Sales Value by Region
5.1.1 Global Neurovascular Devices Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Neurovascular Devices Sales Value by Region (2020-2025)
5.1.3 Global Neurovascular Devices Sales Value by Region (2026-2031)
5.1.4 Global Neurovascular Devices Sales Value by Region (%), (2020-2031)
5.2 Global Neurovascular Devices Sales Volume by Region
5.2.1 Global Neurovascular Devices Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Neurovascular Devices Sales Volume by Region (2020-2025)
5.2.3 Global Neurovascular Devices Sales Volume by Region (2026-2031)
5.2.4 Global Neurovascular Devices Sales Volume by Region (%), (2020-2031)
5.3 Global Neurovascular Devices Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Neurovascular Devices Sales Value, 2020-2031
5.4.2 North America Neurovascular Devices Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Neurovascular Devices Sales Value, 2020-2031
5.5.2 Europe Neurovascular Devices Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Neurovascular Devices Sales Value, 2020-2031
5.6.2 Asia Pacific Neurovascular Devices Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Neurovascular Devices Sales Value, 2020-2031
5.7.2 South America Neurovascular Devices Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Neurovascular Devices Sales Value, 2020-2031
5.8.2 Middle East & Africa Neurovascular Devices Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Neurovascular Devices Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Neurovascular Devices Sales Value
6.2.1 Key Countries/Regions Neurovascular Devices Sales Value, 2020-2031
6.2.2 Key Countries/Regions Neurovascular Devices Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Neurovascular Devices Sales Value, 2020-2031
6.3.2 United States Neurovascular Devices Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Neurovascular Devices Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Neurovascular Devices Sales Value, 2020-2031
6.4.2 Europe Neurovascular Devices Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Neurovascular Devices Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Neurovascular Devices Sales Value, 2020-2031
6.5.2 China Neurovascular Devices Sales Value by Type (%), 2024 VS 2031
6.5.3 China Neurovascular Devices Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Neurovascular Devices Sales Value, 2020-2031
6.6.2 Japan Neurovascular Devices Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Neurovascular Devices Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Neurovascular Devices Sales Value, 2020-2031
6.7.2 South Korea Neurovascular Devices Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Neurovascular Devices Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Neurovascular Devices Sales Value, 2020-2031
6.8.2 Southeast Asia Neurovascular Devices Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Neurovascular Devices Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Neurovascular Devices Sales Value, 2020-2031
6.9.2 India Neurovascular Devices Sales Value by Type (%), 2024 VS 2031
6.9.3 India Neurovascular Devices Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Stryker Corporation
7.1.1 Stryker Corporation Company Information
7.1.2 Stryker Corporation Introduction and Business Overview
7.1.3 Stryker Corporation Neurovascular Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Stryker Corporation Neurovascular Devices Product Offerings
7.1.5 Stryker Corporation Recent Development
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Information
7.2.2 Johnson & Johnson Introduction and Business Overview
7.2.3 Johnson & Johnson Neurovascular Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Johnson & Johnson Neurovascular Devices Product Offerings
7.2.5 Johnson & Johnson Recent Development
7.3 Medtronic
7.3.1 Medtronic Company Information
7.3.2 Medtronic Introduction and Business Overview
7.3.3 Medtronic Neurovascular Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Medtronic Neurovascular Devices Product Offerings
7.3.5 Medtronic Recent Development
7.4 Terumo
7.4.1 Terumo Company Information
7.4.2 Terumo Introduction and Business Overview
7.4.3 Terumo Neurovascular Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Terumo Neurovascular Devices Product Offerings
7.4.5 Terumo Recent Development
7.5 Penumbra
7.5.1 Penumbra Company Information
7.5.2 Penumbra Introduction and Business Overview
7.5.3 Penumbra Neurovascular Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Penumbra Neurovascular Devices Product Offerings
7.5.5 Penumbra Recent Development
7.6 Microport Scientific Corporation
7.6.1 Microport Scientific Corporation Company Information
7.6.2 Microport Scientific Corporation Introduction and Business Overview
7.6.3 Microport Scientific Corporation Neurovascular Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Microport Scientific Corporation Neurovascular Devices Product Offerings
7.6.5 Microport Scientific Corporation Recent Development
7.7 Abbott Vascular
7.7.1 Abbott Vascular Company Information
7.7.2 Abbott Vascular Introduction and Business Overview
7.7.3 Abbott Vascular Neurovascular Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Abbott Vascular Neurovascular Devices Product Offerings
7.7.5 Abbott Vascular Recent Development
7.8 W. L. Gore & Associates
7.8.1 W. L. Gore & Associates Company Information
7.8.2 W. L. Gore & Associates Introduction and Business Overview
7.8.3 W. L. Gore & Associates Neurovascular Devices Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 W. L. Gore & Associates Neurovascular Devices Product Offerings
7.8.5 W. L. Gore & Associates Recent Development
8 Industry Chain Analysis
8.1 Neurovascular Devices Industrial Chain
8.2 Neurovascular Devices Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Neurovascular Devices Sales Model
8.5.2 Sales Channel
8.5.3 Neurovascular Devices Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Neurovascular Devices Market Trends
Table 2. Neurovascular Devices Market Drivers & Opportunity
Table 3. Neurovascular Devices Market Challenges
Table 4. Neurovascular Devices Market Restraints
Table 5. Global Neurovascular Devices Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Neurovascular Devices Revenue Market Share by Company (2020-2025)
Table 7. Global Neurovascular Devices Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global Neurovascular Devices Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Neurovascular Devices Price by Company (2020-2025) & (USD/Unit)
Table 10. Key Manufacturers Neurovascular Devices Manufacturing Base and Headquarters
Table 11. Key Manufacturers Neurovascular Devices Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Neurovascular Devices
Table 13. Global Neurovascular Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurovascular Devices as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Neurovascular Devices Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Neurovascular Devices Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Neurovascular Devices Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Neurovascular Devices Sales Market Share in Value by Type (2020-2025)
Table 20. Global Neurovascular Devices Sales Market Share in Value by Type (2026-2031)
Table 21. Global Neurovascular Devices Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global Neurovascular Devices Sales Volume by Type (2020-2025) & (K Units)
Table 23. Global Neurovascular Devices Sales Volume by Type (2026-2031) & (K Units)
Table 24. Global Neurovascular Devices Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Neurovascular Devices Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Neurovascular Devices Price by Type (2020-2025) & (USD/Unit)
Table 27. Global Neurovascular Devices Price by Type (2026-2031) & (USD/Unit)
Table 28. Global Neurovascular Devices Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Neurovascular Devices Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Neurovascular Devices Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Neurovascular Devices Sales Market Share in Value by Application (2020-2025)
Table 32. Global Neurovascular Devices Sales Market Share in Value by Application (2026-2031)
Table 33. Global Neurovascular Devices Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global Neurovascular Devices Sales Volume by Application (2020-2025) & (K Units)
Table 35. Global Neurovascular Devices Sales Volume by Application (2026-2031) & (K Units)
Table 36. Global Neurovascular Devices Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Neurovascular Devices Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Neurovascular Devices Price by Application (2020-2025) & (USD/Unit)
Table 39. Global Neurovascular Devices Price by Application (2026-2031) & (USD/Unit)
Table 40. Global Neurovascular Devices Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Neurovascular Devices Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Neurovascular Devices Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Neurovascular Devices Sales Value by Region (2020-2025) & (%)
Table 44. Global Neurovascular Devices Sales Value by Region (2026-2031) & (%)
Table 45. Global Neurovascular Devices Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global Neurovascular Devices Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global Neurovascular Devices Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global Neurovascular Devices Sales Volume by Region (2020-2025) & (%)
Table 49. Global Neurovascular Devices Sales Volume by Region (2026-2031) & (%)
Table 50. Global Neurovascular Devices Average Price by Region (2020-2025) & (USD/Unit)
Table 51. Global Neurovascular Devices Average Price by Region (2026-2031) & (USD/Unit)
Table 52. Key Countries/Regions Neurovascular Devices Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Neurovascular Devices Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Neurovascular Devices Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Neurovascular Devices Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions Neurovascular Devices Sales Volume, (2026-2031) & (K Units)
Table 57. Stryker Corporation Company Information
Table 58. Stryker Corporation Introduction and Business Overview
Table 59. Stryker Corporation Neurovascular Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Stryker Corporation Neurovascular Devices Product Offerings
Table 61. Stryker Corporation Recent Development
Table 62. Johnson & Johnson Company Information
Table 63. Johnson & Johnson Introduction and Business Overview
Table 64. Johnson & Johnson Neurovascular Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Johnson & Johnson Neurovascular Devices Product Offerings
Table 66. Johnson & Johnson Recent Development
Table 67. Medtronic Company Information
Table 68. Medtronic Introduction and Business Overview
Table 69. Medtronic Neurovascular Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Medtronic Neurovascular Devices Product Offerings
Table 71. Medtronic Recent Development
Table 72. Terumo Company Information
Table 73. Terumo Introduction and Business Overview
Table 74. Terumo Neurovascular Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Terumo Neurovascular Devices Product Offerings
Table 76. Terumo Recent Development
Table 77. Penumbra Company Information
Table 78. Penumbra Introduction and Business Overview
Table 79. Penumbra Neurovascular Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Penumbra Neurovascular Devices Product Offerings
Table 81. Penumbra Recent Development
Table 82. Microport Scientific Corporation Company Information
Table 83. Microport Scientific Corporation Introduction and Business Overview
Table 84. Microport Scientific Corporation Neurovascular Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Microport Scientific Corporation Neurovascular Devices Product Offerings
Table 86. Microport Scientific Corporation Recent Development
Table 87. Abbott Vascular Company Information
Table 88. Abbott Vascular Introduction and Business Overview
Table 89. Abbott Vascular Neurovascular Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Abbott Vascular Neurovascular Devices Product Offerings
Table 91. Abbott Vascular Recent Development
Table 92. W. L. Gore & Associates Company Information
Table 93. W. L. Gore & Associates Introduction and Business Overview
Table 94. W. L. Gore & Associates Neurovascular Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. W. L. Gore & Associates Neurovascular Devices Product Offerings
Table 96. W. L. Gore & Associates Recent Development
Table 97. Key Raw Materials Lists
Table 98. Raw Materials Key Suppliers Lists
Table 99. Neurovascular Devices Downstream Customers
Table 100. Neurovascular Devices Distributors List
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Neurovascular Devices Product Picture
Figure 2. Global Neurovascular Devices Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Neurovascular Devices Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Neurovascular Devices Sales Volume (2020-2031) & (K Units)
Figure 5. Global Neurovascular Devices Sales Price (2020-2031) & (USD/Unit)
Figure 6. Neurovascular Devices Report Years Considered
Figure 7. Global Neurovascular Devices Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Neurovascular Devices Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Neurovascular Devices Revenue in 2024
Figure 10. Neurovascular Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Aneurysm Coiling & Embolization Devices Picture
Figure 12. Cerebral Balloon Angioplasty & Stenting Systems Picture
Figure 13. Support Devices Picture
Figure 14. Neurothrombectomy Devices Picture
Figure 15. Global Neurovascular Devices Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 16. Global Neurovascular Devices Sales Value Market Share by Type, 2024 & 2031
Figure 17. Global Neurovascular Devices Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 18. Global Neurovascular Devices Sales Volume Market Share by Type, 2024 & 2031
Figure 19. Global Neurovascular Devices Price by Type (2020-2031) & (USD/Unit)
Figure 20. Product Picture of Hospitals
Figure 21. Product Picture of Clinics
Figure 22. Product Picture of Ambulatory Surgical Units
Figure 23. Global Neurovascular Devices Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 24. Global Neurovascular Devices Sales Value Market Share by Application, 2024 & 2031
Figure 25. Global Neurovascular Devices Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 26. Global Neurovascular Devices Sales Volume Market Share by Application, 2024 & 2031
Figure 27. Global Neurovascular Devices Price by Application (2020-2031) & (USD/Unit)
Figure 28. North America Neurovascular Devices Sales Value (2020-2031) & (US$ Million)
Figure 29. North America Neurovascular Devices Sales Value by Country (%), 2024 VS 2031
Figure 30. Europe Neurovascular Devices Sales Value, (2020-2031) & (US$ Million)
Figure 31. Europe Neurovascular Devices Sales Value by Country (%), 2024 VS 2031
Figure 32. Asia Pacific Neurovascular Devices Sales Value, (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Neurovascular Devices Sales Value by Region (%), 2024 VS 2031
Figure 34. South America Neurovascular Devices Sales Value, (2020-2031) & (US$ Million)
Figure 35. South America Neurovascular Devices Sales Value by Country (%), 2024 VS 2031
Figure 36. Middle East & Africa Neurovascular Devices Sales Value, (2020-2031) & (US$ Million)
Figure 37. Middle East & Africa Neurovascular Devices Sales Value by Country (%), 2024 VS 2031
Figure 38. Key Countries/Regions Neurovascular Devices Sales Value (%), (2020-2031)
Figure 39. Key Countries/Regions Neurovascular Devices Sales Volume (%), (2020-2031)
Figure 40. United States Neurovascular Devices Sales Value, (2020-2031) & (US$ Million)
Figure 41. United States Neurovascular Devices Sales Value by Type (%), 2024 VS 2031
Figure 42. United States Neurovascular Devices Sales Value by Application (%), 2024 VS 2031
Figure 43. Europe Neurovascular Devices Sales Value, (2020-2031) & (US$ Million)
Figure 44. Europe Neurovascular Devices Sales Value by Type (%), 2024 VS 2031
Figure 45. Europe Neurovascular Devices Sales Value by Application (%), 2024 VS 2031
Figure 46. China Neurovascular Devices Sales Value, (2020-2031) & (US$ Million)
Figure 47. China Neurovascular Devices Sales Value by Type (%), 2024 VS 2031
Figure 48. China Neurovascular Devices Sales Value by Application (%), 2024 VS 2031
Figure 49. Japan Neurovascular Devices Sales Value, (2020-2031) & (US$ Million)
Figure 50. Japan Neurovascular Devices Sales Value by Type (%), 2024 VS 2031
Figure 51. Japan Neurovascular Devices Sales Value by Application (%), 2024 VS 2031
Figure 52. South Korea Neurovascular Devices Sales Value, (2020-2031) & (US$ Million)
Figure 53. South Korea Neurovascular Devices Sales Value by Type (%), 2024 VS 2031
Figure 54. South Korea Neurovascular Devices Sales Value by Application (%), 2024 VS 2031
Figure 55. Southeast Asia Neurovascular Devices Sales Value, (2020-2031) & (US$ Million)
Figure 56. Southeast Asia Neurovascular Devices Sales Value by Type (%), 2024 VS 2031
Figure 57. Southeast Asia Neurovascular Devices Sales Value by Application (%), 2024 VS 2031
Figure 58. India Neurovascular Devices Sales Value, (2020-2031) & (US$ Million)
Figure 59. India Neurovascular Devices Sales Value by Type (%), 2024 VS 2031
Figure 60. India Neurovascular Devices Sales Value by Application (%), 2024 VS 2031
Figure 61. Neurovascular Devices Industrial Chain
Figure 62. Neurovascular Devices Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Neurovascular Devices in 2031?
The global market size of Neurovascular Devices in 2031 was 297 Million USD.
What was the global market size of Neurovascular Devices in 2025?
Which region is expected to have the highest market share?
What is the annual compound growth rate of the global Neurovascular Devices market size from 2025 to 2031?
Which companies rank high in the global Neurovascular Devices market?
Related Reports
Global Neurovascular Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Neurovascular Devices market size was US$ 3216 million in 2025 and is forecast to reach a readjusted size of US$ 4593 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 76
USD 4250.00
(Single User License)
Global Neurovascular Devices Market Research Report 2026
The global Neurovascular Devices market was valued at US$ 3216 million in 2025 and is anticipated to reach US$ 4593 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 106
USD 2900.00
(Single User License)
Neurovascular Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Neurovascular Devices was estimated to be worth US$ 3216 million in 2025 and is projected to reach US$ 4593 million, growing at a CAGR of 5.3% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 95
USD 3950.00
(Single User License)
Neurovascular Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Neurovascular Devices was estimated to be worth US$ 3195 million in 2024 and is forecast to a readjusted size of US$ 4384 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published Date: 2025-11-05
Pages: 94
USD 3950.00
(Single User License)
Global Neurovascular Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Neurovascular Devices market is projected to grow from US$ 3195 million in 2024 to US$ 4384 million by 2031, at a CAGR of 5.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-09-11
Pages: 127
USD 4900.00
(Single User License)
Global Neurovascular Devices Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Neurovascular Devices was estimated to be worth US$ 3195 million and is forecast to reach approximately US$ 4384 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 125
USD 5900.00
(Single User License)
Global Neurovascular Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Neurovascular Devices market size was US$ 3195 million in 2024 and is forecast to a readjusted size of US$ 4384 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 79
USD 4250.00
(Single User License)
Global Neurovascular Devices Market Insights, Forecast to 2031
Valued at US$ 3216 million in 2024, the global Neurovascular Devices market is forecast to reach US$ 4384 million by 2030, at a CAGR of 5.3% during the forecast period.
Published Date: 2025-02-14
Pages: 123
USD 4900.00
(Single User License)
Global Neurovascular Devices Market Research Report 2025
The global market for Neurovascular Devices was valued at US$ 3195 million in the year 2024 and is projected to reach a revised size of US$ 4384 million by 2031, growing at a CAGR of 5.3% during the forecast period.
Published Date: 2025-02-14
Pages: 80
USD 2900.00
(Single User License)
Neurovascular Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Neurovascular Devices refer to the tools that used to pass through the blood vessels to diagnose and treat diseases and conditions of the brain and nervous system rather than using open surgery. Neurovascular Devices comprise a large segment of medical devices, including embolic coils, neurovascular stents (carotid and intracranial stents), intravascular devices, neurothrombectomy devices, flow diverters, embolic protection device, balloons and stent retrievers.
Published Date: 2024-01-06
Pages: 98
USD 3950.00
(Single User License)
Global Neurovascular Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Neurovascular Devices market size was US$ 3216 million in 2025 and is forecast to reach a readjusted size of US$ 4593 million by 2032 with a CAGR of 5.3% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 76
USD 4250.00 (Single User License)Global Neurovascular Devices Market Research Report 2026
The global Neurovascular Devices market was valued at US$ 3216 million in 2025 and is anticipated to reach US$ 4593 million by 2032, at a CAGR of 5.3% from 2026 to 2032.
Published: 2026-01-04
Pages: 106
USD 2900.00 (Single User License)Neurovascular Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Neurovascular Devices was estimated to be worth US$ 3216 million in 2025 and is projected to reach US$ 4593 million, growing at a CAGR of 5.3% from 2026 to 2032.
Published: 2026-01-04
Pages: 95
USD 3950.00 (Single User License)Neurovascular Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Neurovascular Devices was estimated to be worth US$ 3195 million in 2024 and is forecast to a readjusted size of US$ 4384 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published: 2025-11-05
Pages: 94
USD 3950.00 (Single User License)Global Neurovascular Devices Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Neurovascular Devices market is projected to grow from US$ 3195 million in 2024 to US$ 4384 million by 2031, at a CAGR of 5.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-09-11
Pages: 127
USD 4900.00 (Single User License)Global Neurovascular Devices Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Neurovascular Devices was estimated to be worth US$ 3195 million and is forecast to reach approximately US$ 4384 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 125
USD 5900.00 (Single User License)Global Neurovascular Devices Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Neurovascular Devices market size was US$ 3195 million in 2024 and is forecast to a readjusted size of US$ 4384 million by 2031 with a CAGR of 5.3% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 79
USD 4250.00 (Single User License)Global Neurovascular Devices Market Insights, Forecast to 2031
Valued at US$ 3216 million in 2024, the global Neurovascular Devices market is forecast to reach US$ 4384 million by 2030, at a CAGR of 5.3% during the forecast period.
Published: 2025-02-14
Pages: 123
USD 4900.00 (Single User License)Global Neurovascular Devices Market Research Report 2025
The global market for Neurovascular Devices was valued at US$ 3195 million in the year 2024 and is projected to reach a revised size of US$ 4384 million by 2031, growing at a CAGR of 5.3% during the forecast period.
Published: 2025-02-14
Pages: 80
USD 2900.00 (Single User License)Neurovascular Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Neurovascular Devices refer to the tools that used to pass through the blood vessels to diagnose and treat diseases and conditions of the brain and nervous system rather than using open surgery. Neurovascular Devices comprise a large segment of medical devices, including embolic coils, neurovascular stents (carotid and intracranial stents), intravascular devices, neurothrombectomy devices, flow diverters, embolic protection device, balloons and stent retrievers.
Published: 2024-01-06
Pages: 98
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now